CAD 1.0
(21.95%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.30 CAD | -76.47% |
2022 | -0.17 CAD | 15.0% |
2021 | -0.20 CAD | -81.82% |
2020 | -0.11 CAD | -469.95% |
2019 | -0.02 CAD | -19200.0% |
2018 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q2 | -0.19 CAD | -279.24% |
2023 Q4 | -0.03 CAD | -1.34% |
2023 Q1 | -0.05 CAD | -25.25% |
2023 Q3 | -0.03 CAD | 84.32% |
2022 Q1 | -0.05 CAD | 23.8% |
2022 Q2 | -0.05 CAD | -14.32% |
2022 FY | - CAD | 15.0% |
2022 Q4 | -0.04 CAD | -15.61% |
2022 Q3 | -0.03 CAD | 34.35% |
2021 Q1 | -0.04 CAD | 9.83% |
2021 FY | - CAD | -81.82% |
2021 Q4 | -0.06 CAD | -29.0% |
2021 Q3 | -0.05 CAD | 12.99% |
2021 Q2 | -0.05 CAD | -25.06% |
2020 Q2 | -0.01 CAD | -958.33% |
2020 Q1 | -0.00 CAD | 91.11% |
2020 FY | - CAD | -469.95% |
2020 Q4 | -0.05 CAD | -141.41% |
2020 Q3 | -0.02 CAD | -55.91% |
2019 Q3 | -0.01 CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q4 | -0.01 CAD | -145.45% |
2019 FY | - CAD | -19200.0% |
2018 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 33.333% |
Asep Medical Holdings Inc | -0.13 CAD | -130.769% |
BetterLife Pharma Inc. | -0.03 CAD | -1036.364% |
BioVaxys Technology Corp. | -0.06 CAD | -423.56% |
ChitogenX Inc. | -0.02 CAD | -1308.451% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | -631.707% |
Entheon Biomedical Corp. | -0.05 CAD | -490.551% |
Gemina Laboratories Ltd. | -0.07 CAD | -316.667% |
Glow Lifetech Corp. | -0.03 CAD | -941.667% |
Lexston Life Sciences Corp. | -0.02 CAD | -1204.348% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | -3160.87% |
Doseology Sciences Inc. | -0.08 CAD | -276.412% |
MYND Life Sciences Inc. | -0.03 CAD | -834.579% |
Nova Mentis Life Science Corp. | -0.01 CAD | -3514.458% |
PharmaTher Holdings Ltd. | -0.04 CAD | -749.858% |
PreveCeutical Medical Inc. | -0.00 CAD | -12400.0% |
Telescope Innovations Corp. | -0.12 CAD | -150.0% |